The World Health Organization (WHO) has disclosed that over 846 million people aged 15 to 49—more than one in five individuals in this age group globally—are living with the genital herpes infection.
The statistics is part of a report released by WHO on Wednesday, which also estimates that 42 million people acquire a new genital herpes infection annually—equivalent to one new case every second.
While many infections remain asymptomatic, a significant number of individuals experience painful genital sores and recurring blisters, which can disrupt daily life and require frequent medical intervention.
Director of WHO’s Global HIV, Hepatitis, and Sexually Transmitted Infections Programmes, Dr. Meg Doherty, stressed the urgent need for enhanced prevention and treatment strategies to curb the transmission of herpes.
She added that addressing genital herpes could also have a ripple effect in reducing the spread of HIV.
A Medical Officer within WHO’s Department of Sexual and Reproductive Health and Research,Sami Gottlieb, highlighted the pervasive stigma associated with genital herpes.
The stigma, she said, has hindered open conversations and robust efforts to combat the infection despite its widespread impact.
“Expanded research and investment in developing new herpes vaccines and therapies, alongside their equitable distribution, are critical to improving the quality of life for millions worldwide,” Gottlieb emphasized.
Although condoms are not entirely effective in preventing herpes transmission, Gottlieb noted that consistent and correct usage significantly reduces risk.
She also advised individuals experiencing active symptoms to abstain from sexual activity, as the infection is most contagious during outbreaks.
The WHO recommends HIV testing for those with genital herpes symptoms and, if necessary, pre-exposure prophylaxis (PrEP) to prevent HIV.
These measures align with the organization’s Global Health Sector Strategy on HIV, Viral Hepatitis, and Sexually Transmitted Infections 2022–2030, which aims to increase awareness and improve management of genital herpes.
The report underscored the substantial economic toll of genital herpes, with annual costs estimated at $35 billion globally. This includes healthcare expenses and productivity losses associated with the infection.
To address these challenges, WHO has called for heightened awareness, broader access to antiviral medications, and strengthened integration of herpes prevention with HIV initiatives.
“Genital herpes is not just a personal health issue; it’s a global health priority requiring urgent attention and action,” Gottlieb said.
